Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLink[1] mobile app and LibreView[2] cloud-based system). 
Fujitsu announced development of Fujitsu Healthcare Solution Healthcare Personal service Platform, a platform-as-a-service (PaaS) for the integrated management of consumer-facing offerings based on health and medical information. The new service can aggregate and integrate an individual's personal health record, enabling the safe and secure storage and use of such health and medical information. 
Medicus AI GmbH announced the completion of the first tranche of its Series A funding round at €2.75 million, with the purview to close the second tranche of €2.25 million over the coming months.
Medicus works with diagnostic labs to deliver smart features and insights to doctors, in terms of smart testing and diagnosis support, and to patients, in the form of visual and interactive reports, powering continuous healthcare and coaching across all digital platforms.
Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology in clinical trials. This collaboration underscores Boehringer Ingelheim's commitment to healthcare innovation and marks the first time that blockchain technology will be explored in a clinical trial setting in Canada. 
Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their pitch deck. 
The Berlin-based start-up Better@Home, founded in the summer of 2018 and operating in Germany, successfully completed its first financing round in December with more than 1 million euros. The investors are CompuGroup Medical Research GmbH, an undisclosed healthcare consultant, and B.I.F. GmbH, the holding company of Hamburg-based business angel Wolfgang Biedermann.